Skip to main content

Table 3 Hazard Ratio (95% CI) from subgroup analyses for risks of CVD events at pre-defined levels of HbA1c

From: Associations between glycated hemoglobin and the risks of incident cardiovascular diseases in patients with gout

Subgroup

No. of events/no. of patients

HbA1c (%)

4.5

5.0

5.5

6.0

6.5

7.0

7.5

8.0

By sex

 Male

1013/6143

0.76 (0.54–1.07)

0.64 (0.51–0.80)

0.68 (0.57–0.81)

0.85 (0.78–0.93)

0.95 (0.91–0.99)

Ref.

1.05 (0.99–1.10)

1.09 (0.98–1.21)

 Female

82/542

1.38 (0.32–6.05)

1.09 (0.44–2.66)

0.90 (0.40–2.02)

0.92 (0.65–1.30)

0.96 (0.85–1.08)

Ref.

1.04 (0.91–1.20)

1.09 (0.82–1.43)

By age

  < 65 years

635/4702

0.67 (0.43–1.03)

0.64 (0.48–0.85)

0.72 (0.58–0.89)

0.87 (0.79–0.96)

0.96 (0.91–1.01)

Ref.

1.04 (0.98–1.10)

1.08 (0.96–1.21)

  ≥ 65 years

460/1983

0.75 (0.45–1.27)

0.57 (0.41–0.80)

0.55 (0.41–0.74)

0.76 (0.64–0.89)

0.91 (0.83–1.01)

Ref.

1.08 (0.97–1.20)

1.16 (0.94–1.44)

By diabetes mellitus

 Without diabetes

831/5840

0.86 (0.59–1.25)

0.69 (0.55–0.87)

0.76 (0.63–0.92)

0.92 (0.79–1.07)

0.96 (0.89–1.04)

Ref.

1.04 (0.96–1.12)

1.08 (0.93–1.26)

 With diabetes

264/845

1.00 (0.42–2.36)

0.94 (0.53–1.65)

0.88 (0.64–1.22)

0.85 (0.65–1.11)

0.90 (0.76–1.06)

Ref.

1.10 (1.01–1.20)

1.20 (1.05–1.38)

By MH status

 MH

46/572

0.60 (0.10–3.53)

0.39 (0.10–1.51)

0.44 (0.11–1.77)

0.59 (0.20–1.74)

0.77 (0.45–1.32)

Ref.

1.30 (0.76–2.23)

1.70 (0.58–5.00)

 MU

1039/6088

0.61 (0.44–0.85)

0.50 (0.42–0.60)

0.53 (0.46–0.62)

0.76 (0.71–0.82)

0.92 (0.88–0.96)

Ref.

1.06 (1.01–1.11)

1.13 (1.03–1.24)

  1. CI confidence interval, CVD cardiovascular disease, HbA1c hemoglobin A1c, MH metabolically healthy, MU metabolically unhealthy, Ref reference